Pharmacokinetics and postoperative analgesia of epidural tramadol: A prospective, pilot study

Abstract Background: Tramadol, a centrally acting analgesic drug, can be administered via multiple routes and is generally well tolerated. Objective: This study was designed to assess the pharmacokinetics of epidural tramadol administered preoperatively in Japanese patients undergoing upper abdomina...

Full description

Saved in:
Bibliographic Details
Published inCurrent therapeutic research Vol. 69; no. 1; pp. 49 - 55
Main Authors Kubota, Rie, PharmD, Komiyama, Takako, PharmD, Miwa, Yasuko, PhD, Ide, Takayuki, MS, Toyoda, Hajime, PhD, Asanuma, Fumiki, PhD, Yamada, Yoshinori, PhD
Format Journal Article
LanguageEnglish
Published New York, NY EM Inc USA 01.02.2008
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Background: Tramadol, a centrally acting analgesic drug, can be administered via multiple routes and is generally well tolerated. Objective: This study was designed to assess the pharmacokinetics of epidural tramadol administered preoperatively in Japanese patients undergoing upper abdominal surgery. Method: Japanese patients who were scheduled to undergo upper abdominal surgery in The Kitasato Institute Hospital, Tokyo, Japan, were included. Patients received tramadol 2 mg/kg with 5 mL of 1% mepivacaine epidurally 10 minutes before incision. The serum concentration of tramadol was determined by high-performance liquid chromatography for 21 hours after administration. Serum concentration was determined before tramadol administration and 10, 20, 30, and 60 minutes after tramadol administration, first postoperative night, and first postoperative day. Pain score and adverse events (AEs) were assessed at 1, 3, 6, 12, 18, 24, 36, and 48 hours after surgery by patient interview. Results: Eleven patients were assessed for enrollment. Seven patients (6 men, 1 woman; mean [SD] age, 61.3 [12.6] years; mean [SD] weight, 59.9 [8.9] kg) provided consent and completed the study. The mean (SD) serum Cmax of tramadol was 1385.5 (390.8) ng/mL, Tmax was 0.33 (0.22) hour, and terminal elimination half-life (t1/2β ) was 10.5 (2.3) hours. Four patients complained of nausea; however, only 1 patient was administered an antiemetic. No other AEs were reported. Conclusion: This pilot study found that epidural tramadol administered before incision induced a Cmax within 30 minutes of administration. The drug was detected in serum at ∼21 hours after surgery.
ISSN:0011-393X
1879-0313
DOI:10.1016/j.curtheres.2008.02.006